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Background: Subepithelial fibrosis is a characteristic hallmark of airway remodeling in asthma. A critical regulator of
fibrosis, transforming growth factor β (TGF-β), can induce airway remodeling in epithelial cells through induction of
epithelial-mesenchymal transition (EMT). Vitamin D has immunomodulatory functions, however, its effect on controlling
subepithelial fibrosis is not known.
Methods: Human bronchial epithelial cells (BEAS-2B) were exposed to calcitriol followed by stimulation with TGF-β1
or TGF-β2. The protein expression and mRNA transcripts for E-cadherin, Snail, vimentin, and N-cadherin were analyzed
by Western blot and qPCR. An invasion assay and scratch wound assay were performed to identify the migratory
properties of the cells following treatments.
Results: TGF-β1 decreased E-cadherin expression and increased protein expression and mRNA transcripts of Snail,
vimentin, and N-cadherin together with increased cell invasion and migration. TGF-β2 elicited migratory response
similar to TGF-β1 but induced the expression of EMT markers differently from that by TGF-β1. Calcitriol attenuated
TGF-β1- and TGF-β2-induced cell motility. Also, calcitriol inhibited the expression of EMT markers in TGF-β1-treated
epithelial cells with less effect on TGF-β2.
Conclusions: These data suggest that calcitriol inhibits both migration and invasion induced by TGF-β1 and TGF-β2
in human airway epithelial cells. However, the regulatory effect of vitamin D in epithelial-mesenchymal transition was
more effective to TGF-β1-induced changes. Thus, calcitriol could be a potential therapeutic agent in the prevention
and management of subepithelial fibrosis and airway remodeling.Background
Asthma afflicts more than 300 million people worldwide
and is one of the most common chronic disorders of
childhood that affects an estimated 6.2 million children
under the age of 18 [1]. Asthma is a chronic inflamma-
tory disease that results in the narrowing of the airways,
tightening of the chest, shortness of breath, and cough-
ing. The hallmarks of asthma include airway obstruction,
chronic wheezing, airway hyperresponsiveness, airway
remodeling, inflammation, and mucus hypersecretion.
While current treatments include corticosteroids, leuko-
triene antagonists, and long-acting β2 agonists, these
therapies are not effective in preventing or reversing
airway remodeling in patients suffering from chronic* Correspondence: DKAGR@creighton.edu
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article, unless otherwise stated.allergic asthma [2]. In addition, the beneficial anti-
inflammatory effect of corticosteroids is not without
many adverse effects. Therefore, further understanding
of the mechanisms underlying airway remodeling is re-
quired to develop therapies that target the molecules
involved in structural changes, including fibrosis and
epithelial thickening.
Recently, vitamin D has received more attention as an
effective immunomodulator in extra-musculoskeletal tis-
sues. Vitamin D is a steroid hormone that is synthesized
from cholesterol in the skin, or can be ingested through
dietary sources. Vitamin D goes through sequential hy-
droxylation steps in the liver and kidney resulting in its
final active form, 1,25(OH)2D3 or calcitriol. Calcitriol
regulates bone, calcium, and phosphate metabolism
through vitamin D receptor (VDR). The VDR forms a
heterodimer with the retinoid X receptor and regulates
gene expression in the nucleus. The 1,25(OH)2D3 can
also bind to the VDR on the plasma membrane to exertCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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[3]. The increased incidence of asthma [4] associated
with increased vitamin D deficiency might suggest a
link between the two in the pathogenesis of asthma
[5-7]. Previous studies suggest that vitamin D status is
a strong predictor of childhood asthma, with deficiency
more frequent in children suffering from asthma com-
pared to non-asthmatic controls [8,9]. This association
of vitamin D deficiency and asthma is not limited to
children and includes prospective studies that suggest
vitamin D insufficiency and deficiency are linked with
severe and uncontrolled adult asthma [10]. While this
data suggests that vitamin D deficiency results in an
increased risk for asthma and allergy, the amount of
vitamin D that might be required to prevent or lessen
the severity of an asthma attack is still unknown. A pro-
spective study found that vitamin D supplementation in
asthmatic children prevented asthma exacerbation trig-
gered by acute respiratory infection [11]. However, other
reports do not suggest a role for vitamin D supplementa-
tion. In two recent studies vitamin D supplementation in
asthma patients did not result in significant difference
compared to the placebo group [12,13].
Airway remodeling, a consequence of long-standing
asthma, reduces lung function and is not regulated well
with current therapies. There is currently limited infor-
mation on the role of vitamin D as a potential inhibitor
of airway remodeling in asthma. Previous work has dem-
onstrated that vitamin D plays a role in airway smooth
muscle, but the role of vitamin D in the epithelium is
not well understood [14,15]. One of the key cytokines
involved in the airway remodeling process is TGF-β,
which is released from degranulated eosinophils and
mast cells to induce multiple localized effects resulting
in airway remodeling [16-18].
Airway epithelial cells are located between the host
and external environment, designating their key role in
the protection of the host against microorganisms, dust,
and other allergens. TGF-β has been suggested to initi-
ate fibrosis in the airway epithelial cell through activa-
tion of epithelial mesenchymal transition (EMT) signals
[19,20]. One of the main transcription factors involved
in this process is Snail. It has been demonstrated that
Snail forms a transcriptional repressor with Smad3 and
Smad4 to promote EMT [21]. Activation of EMT signal-
ing permits the cells to differentiate into myofibroblasts,
enabling invasion and migration outside of the epithe-
lium. Increased myofibroblasts in the submucosa secrete
collagen and extracellular matrix, thereby, contributing
to the subepithelial fibrosis in airway remodeling [22].
While vitamin D has been shown to have immuno-
modulatory properties in immune cells [10] and airway
smooth muscle cells [15], the properties of vitamin D in
epithelial cells are currently lacking. Here, we investigatedthe effect of active form of vitamin D, calcitriol, and TGF-
β on EMT markers in bronchial epithelial cells. While
most studies examining EMT in vitro utilize TGF-β1,
there is little information on the effect of TGF-β2, which
has also been identified as a contributor to the develop-
ment of asthma [23,24]. Our findings suggest that calci-
triol can inhibit epithelial cell motility induced by both
TGF-β isoforms, but calcitriol-induced inhibition of EMT
characteristics in response to TGF-β1 and TGF-β2 could
involve different molecular mechanisms.
Methods
Cell culture
Bronchial epithelial cells, BEAS-2B cells (ATCC, Manassas,
VA) were seeded on 6-well culture dishes at 1.5 × 105 cells/
ml and cultured in BepiCM media (ScienCell, Carlsbad,
CA) supplemented with 10% FBS. When cells reached 50%
confluence, the media was changed and cells received
serum-free media for 24 hours. Cells were then subjected
to stimulation with either 0.1% 95% ethanol (vehicle) or
100 nM calcitriol (Sigma-Aldrich, St. Louis, MO) for
24 hours. TGF-β1 or TGF-β2 (PeproTech, Rocky Hill, NJ)
were then added to the cells for an additional 48 hours.
RNA isolation and qPCR
Total RNA was isolated using the RNeasy Plus Mini kit
(Qiagen, Valencia, CA) according to manufacturer’s in-
structions. RNA concentration was quantified using a
Nanodrop (Thermo‐Scientific, Rockford, IL). First-strand
cDNA synthesis was performed using 1 μg total RNA
with oligo dT, 5X reaction buffer, MgCl2, dNTP mix,
RNAse inhibitor and Improm II reverse transcriptase as
per manufacturer’s instructions in the Improm II reverse
transcription kit (Promega, Madison, WI). Following the
first strand synthesis, real time PCR was performed using
3.2 ng of cDNA, 10 μl SYBR Green PCR Master Mix
(BioRad Laboratories, Hercules, CA) and forward and re-
verse primers (10 pmol/μl) (Integrated DNATechnologies,
Coralville, IA) using a real time PCR system (CFX96,
BioRad Laboratories, Hercules, CA). Relative mRNA
transcripts levels were normalized against an internal
housekeeping gene and sample differences determined
using ΔΔCt relative method. A complete list of the primers
and their sequences is provided in Table 1.
Western blot
BEAS-2B cells were washed with ice-cold PBS and incu-
bated with 0.15 ml of modified RIPA lysis buffer with
protease and phosphatase inhibitor cocktails 1 and 2
(Sigma-Aldrich, St. Louis, MO). Protein concentration
was determined by the BCA protein assay kit (Sigma-
Aldrich, St. Louis, MO) according to the manufacturer’s
instructions. Each sample of protein containing 15 μg of
protein was mixed with equal volume of Laemmli buffer
Table 1 Primer sequences used for qPCR experiments
Gene Sequence
E-cadherin Forward AAG AAG CTG GCT GAC ATG TAC GGA
Reverse CCA CCA GCA ACG TGA TTT CTG CAT
Snail Forward TTT CTG GTT CTG TGT CCT CTG CCT
Reverse TGA GTC TGT CAG CCT TTG TCC TGT
MMP2 Forward AGA AGG ATG GCA AGT ACG GCT TCT
Reverse AGT GGT GCA GCT GTC ATA GGA TGT
MMP9 Forward ATT TCT GCC AGG ACC GCT TCT ACT
Reverse CAG TTT GTA TCC GGC AAA CTG GCT
18S Forward TCA ACT TTC GAT GGT AGT CGC CGT
Reverse TCC TTG GAT GTG GTA GCC GTT TCT
GAPDH Forward TCG ACA GTC AGC CGC ATC TTC TTT
Reverse ACC AAA TCG GTT GAC TCC GAC CTT
N-cadherin Forward TGT GGG AAT CCG ACG AAT GGA TGA
Reverse TGG AGC CAC TGC CTT CAT AGT CAA
Vimentin Forward AGA ACC TGC AGG AGG CAG AAG AAT
Reverse TTC CAT TTC ACG CAT CTG GCG TT
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solved on 10-20% polyacrylamide gel (BioRad, Hercules,
CA). Proteins were transferred onto a nitrocellulose
membrane (BioRad, Hercules, CA), which were subse-
quently blocked with 5% non-fat dry milk for one hour.
The membrane was then incubated overnight at 4°C
with E-cadherin (ab15148, Abcam, Cambridge, MA),
Snail (NBP1-19529, Novus, Littleton, CO), and Vimentin
(sc-6260, Santa Cruz, Dallas, Texas). Following, a horse-
radish peroxidase-conjugated secondary antibody (Novus,
Littleton, CO) was added to the membrane. The protein
expression was detected by ECL chemiluminescence
detection reagents (Bio-Rad, Hercules, CA). The immu-
noreactivity was captured by the ChemiDoc™ MP
System (Bio-Rad Laboratories, Hercules, CA). Mem-
branes were stripped and reprobed for N-cadherin and
GAPDH. Results were normalized against housekeeping
gene GAPDH.
Zymography
Supernatant from the stimulated BEAS-2B cells were
collected, centrifuged to remove debris, and subjected to
gelatin zymography. An equal volume of conditioned
media from each sample was then run on an 8% SDS-
PAGE containing gelatin (1.0 mg/ml). Following electro-
phoresis, the gels were washed in Triton X-100 and
incubated for 18 hours in 50 mM Tris–HCl buffer con-
taining 0.2 mol/L NaCl and 10 mmol/L CaCl2. Gels were
stained with Brilliant Blue R250 and destained. MMP
activity was assessed by observing white bands against a
dark background.Invasion assay
Following stimulation with calcitriol and/or TGF-β1/
TGF-β2, BEAS-2B cells were isolated and reseeded onto
250 μg/ml of growth factor reduced Matrigel™ coated
transwell inserts at 1.5 × 105 cells/ml. Supernatant from
these cells was used as the chemoattractant. After
48 hours, cells on the top of the inserts were removed
and the remaining cells on the bottom were fixed and
stained with the Diff-Quick stain kit (Fisher Scientific,
Waltham, MA). The density of the invasive cells on the
bottom of the insert was examined by counting the cells
in five fields per insert locations under a light micro-
scope at 20x magnification.
Scratch wound healing assay
BEAS-2B cells were seeded, allowed to reach 75% con-
fluency, and serum starved for 24 hours and subse-
quently stimulated with 100 nM calcitriol for 24 hr. A
wound line was generated by using a sterile 10 μl pipette
tip followed by the addition of 10 ng/ml TGF-β1 or
TGF-β2 for an additional 48 hours. Images were ob-
tained at 0 and 48 hours using a light microscope at 20x
magnification with a digital camera under bright field
illumination using an Olympus CKX41 microscope.
The distance between the edges of the wound was
measured at six different areas from the wound edge-
to-edge using ImageJ software. The area between the
wound edges was measured at each time point using
ImageJ software (as described previously by Dr. Kees
Straatman, Advanced Imaging Facilities, University of
Leicester, Leicester, UK). The measurements were then
converted into a percentage using the formula: % of
wound closure = (measurement at 48 h/measurement at
time 0 h) * 100; then to obtain the % of wound closure:
100% - % of wound remaining [25].
Data analysis
Data is expressed as mean ± SEM from three or four in-
dependent experiments. Multiple group comparison was
performed using one-way analysis of variance with a
Dunnett or Tukey post–hoc test. GraphPad Prism v5.0
was used to analyse data with a p value of <0.05 consid-
ered significant.
Results
TGF-β1 induces EMT characteristics
EMT is defined by changes in gene expression in which
epithelial markers such as E-cadherin decrease while
mesenchymal markers such as N-cadherin and vimentin
increase. BEAS-2B cells were stimulated with increasing
doses of TGF-β1 ranging from 0.1 ng/ml up 50 ng/ml.
E-cadherin, Snail, vimentin, and N-cadherin mRNA and
protein expression were quantified by real time qPCR
and Western blotting, respectively. TGF-β1 significantly
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and protein levels at 5, 10, and 50 ng/ml (Figure 1A). A
significant increase in Snail mRNA expression was ob-
served at 5, 10, and 50 ng/ml and an increase in protein
expression at 10 and 50 ng/ml (Figure 1B). A significant
increase in vimentin mRNA expression was detected at
5, 10, and 50 ng/ml in which a significant increase in
protein expression was observed following treatment
with 5, 10, and 50 ng/ml of TGF-β1 (Figure 1C). A sig-
nificant increase in N-cadherin mRNA expression was
noted at 10 ng/ml and 50 ng/ml. This was associated
with a significant increase in N-cadherin protein expres-
sion observed at 10 ng/ml (Figure 1D). Based on these
observations, a concentration of 10 ng/ml was chosen
for future experiments.
Time course responses to TGF-β1 were tested as well
on the markers of EMT. Significant decrease in E-
cadherin mRNA was observed at 12, 24, 48, and 72 hours
while significant changes in E-cadherin protein expres-
sion were found at 48 and 72 hours post TGF-β1 stimu-
lation (Figure 2A). Increase in Snail mRNA transcripts
was observed 2, 24, 48, and 72 hours post TGF-β1
stimulation. Noteworthy increases in Snail protein ex-
pression were noticed at 48 and 72 hours post TGF-β1
stimulation (Figure 2B). Vimentin mRNA expression
was increased at 12, 24, 48, and 72 hours while the
increase in vimentin protein was prominent at 48 and
72 hours only (Figure 2C). Significant increases in N-
cadherin mRNA transcript levels were seen at 12, 24, 48,
and 72 hours, while increase in N-cadherin protein
levels were observed at 12, 24, 48, and 72 hoursFigure 1 mRNA and protein expression changes in BEAS-2B cells upo
with increasing doses of TGF-β1 starting from 0.1 ng/ml and up to 50 ng/m
the expression of A: E-cadherin, B: Snail, C: Vimentin, D: N-cadherin, and by
Protein and mRNA expression levels were normalized to the housekeeping
control untreated cells. Data is presented as mean ± SEM n =4, *p <0.05, **(Figure 2D). Based on these findings, a time of 48 hours
was chosen for subsequent experiments.
Calcitriol induces E-cadherin mRNA expression changes in
BEAS-2B cells
BEAS-2B cells stimulated with calcitriol increased E-
cadherin mRNA transcripts when cells were treated with
100 nM calcitriol from 2 to 48 hours, with a significant
increase observed at 24 hours (Figure 3A). E-cadherin
mRNA levels were then detected following treatment
with increasing doses of calcitriol following a 24 hours
stimulation. Significant increases were noted at 50 nM
and 100 nM of calcitriol (Figure 3B).
Morphological changes induced by TGF-β1, TGF-β2, and
calcitriol
Stimulation with TGF-β1 and TGF-β2 induced morpho-
logical changes in BEAS-2B cells consistent with EMT
(Figure 4). Cells stimulated with either TGF-β1 or TGF-β2
developed an elongated, spindle fibroblast-like morphology
with reduced cell-cell contact (Figure 4). Such changes in
the morphology of the cells were prevented by the addition
of calcitriol prior to the stimulation with TGF-β1 and
TGF-β2. The morphology of the cells in the presence of
calcitriol was similar to that in the control cells maintain-
ing the typical epithelial cobblestone pattern.
Calcitriol regulates TGF-β-mediated EMT mRNA and protein
expression changes in BEAS-2B cells
Calcitriol has been shown to be a potential inhibitor
of fibrosis [26]. Here, we addressed the potential ofn TGF-β1 dose response treatment. BEAS-2B cells were stimulated
l for 72 hours. Total RNA and protein were isolated and assessed for
means of quantitative real-time PCR and western blot respectively.
GAPDH and calculated as mean level of induction in comparison to
p <0.01, and ***p <0.001 by one-way ANOVA.
Figure 2 mRNA and protein expression changes in BEAS-2B cells upon TGF-β1 time course. BEAS-2B cells were stimulated with 10 ng/ml
of TGF-β1 at 72, 48, 24, 12, and 2 hours. Untreated control cells were used as a control. Total RNA was isolated and assessed for the expression of
A: E-cadherin, B: Snail, C: Vimentin, D: N-cadherin, and by means of quantitative real-time PCR. Expression levels were normalized to the housekeeping
18 s and calculated as mean level of induction in comparison to control untreated cells. Data is presented as mean ± SEM n =3, *p <0.05, **p <0.01,
and ***p <0.001 by one-way ANOVA. Total protein was isolated and assessed for the expression of E-cadherin, Snail, N-cadherin, Vimentin, and GAPDH
by means of western blot analysis. Expression levels were normalized to the housekeeping gene GAPDH and calculated as mean level of induction in
comparison to control untreated cells. Data is presented as mean ± SEM n =4, *p <0.05, **p <0.01, and ***p <0.001 by one-way ANOVA.
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determined by EMT markers. BEAS-2B cells were pre-
treated with 100 nM calcitriol for 24 hours and subse-
quently stimulated with TGF-β1 or TGF-β2 for an
additional 48 hours. Analysis of the EMT markers deter-
mined that a decrease in E-cadherin mRNA was ob-
served after TGF-β1 and TGF-β2 treatment (Figure 5A
left panel). Calcitriol prevented TGF-β1-mediated de-
creases in E-cadherin protein expression as E-cadherinFigure 3 mRNA expression changes in BEAS-2B cells upon calcitriol ti
BEAS-2B cells for 2, 6, 12, 24 and 48 hours. Total RNA was isolated and ana
normalized to the housekeeping gene 18 s and calculated as mean level of in
as mean ± SEM n =3, *p <0.05, by one-way ANOVA. For calcitriol dose respo
doses of calcitriol starting from 0.1 nM and up to 100 nM for 24 hours. Tot
E-cadherin (B). Data is presented as ± SEM n =3, *p <0.05, **p <0.01 one-wprotein levels were kept at basal levels (Figure 5A right
panel). Snail protein expression was increased following
TGF-β1 stimulation that was impeded by the presence
of calcitriol (Figure 5B right panel). This was not
reflected in the mRNA data for Snail, however TGF-β2
increased Snail mRNA transcript levels, which was
inhibited by calcitriol treatment (Figure 5B left panel).
While no significant TGF-β1 mediated changes in vimen-
tin or N-cadherin were observed in the mRNA (Figures 5Cme course and dose response. Calcitriol (100 nM) was added to
lyzed for the expression of E-cadherin by qPCR. Expression levels were
duction in comparison to control untreated cells (A). Data is presented
nse, response treatment BEAS-2B cells were stimulated with increasing
al RNA and protein were isolated and assessed for the expression of
ay ANOVA.
Figure 4 Morphological changes induced by TGF-β1, TGF-β2, and Calcitriol. BEAS-2B cells were treated with 0.1% vehicle or 100 nM calcitriol for
24 hours. 10 ng/ml of TGF-β1 or 10 ng/ml of TGF-β2 was added for an additional 48 hours. Pictures were taken with bright field illumination using an
Olympus CKX41 microscope.
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N-cadherin were found following calcitriol pretreatment
and subsequent TGF-β1 stimulation (Figures 5C and 5D
right panel). Calcitriol also prevented the TGF-β2
mediated increase in N-cadherin protein expression
(Figure 5D right panel).
Calcitriol prevents TGF-β-mediated EMT: MMP2 and MMP9
mRNA and protein expression changes in BEAS-2B cells
EMT has been demonstrated to be involved cellular
migration and invasion, processes directed by MMPs.
Treatment of BEAS-2B cells with TGF-β1 and TGF-β2
resulted in a significant increase in MMP2 and MMP9
mRNA expression (Figure 6A and Figure 6B). Pretreat-
ment with calcitriol prevented TGF-β2 facilitated in-
crease in MMP2 expression (Figure 6A) and TGF-β1mediated increase in MMP9 (Figure 6B). The activity of
the MMPs was detected using gelatin zymography. Su-
pernatants from TGF-β1 and TGF-β2 stimulated cells
show an upregulated pro-MMP2 protein (latent MMP2)
and an increase in active MMP9 (Figure 6C).
Calcitriol inhibits TGF-β-induced invasiveness and migration
of BEAS-2B cells
To assess the ability of TGF-β-treated BEAS-2B cells
to undergo another EMT characteristic, mobility, an in-
vasion assay and scratch wound healing assay were
utilized. Matrigel™ coated inserts were removed and the
number of cells invading through were counted (repre-
sentative images Figure 7A). Cells treated with TGF-β1
and TGF-β2 had a 70% increase in invasion compared to
unstimulated and calcitriol stimulated BEAS-2B cells.
Figure 5 Calcitriol regulates TGF-β-mediated EMT mRNA and protein expression changes in BEAS-2B cells. BEAS-2B cells were stimulated
with the active form of Vitamin D, calcitriol (100 nM). After 24 hours, TGF-β1 (10 ng/ml) or TGF-β2 (10 ng/ml) was added to the cells for an additional
48 hours. Total RNA was isolated and assessed for the expression of A: E-cadherin, B: Snail, C: Vimentin, D: N-cadherin (left panels) by means of quantitative
real-time PCR. Expression levels were normalized to the housekeeping 18 s and calculated as mean level of induction in comparison to 0.1%
vehicle control cells. Data is presented as mean ± SEM n =4. Total protein was isolated and assessed for the expression of A: E-cadherin, B: Snail,
C: Vimentin, D: N-cadherin (right panels), and GAPDH by means of western blot analysis. Expression levels were normalized to the housekeeping gene
GAPDH and calculated as mean level of induction in comparison to 0.1% vehicle control cells. Data is presented as mean ± SEM n =3. Both qRT-PCR
and western blot analysis were analyzed by one-way ANOVA *p <0.05, **p <0.01, and ***p <0.001 compared to control, #p <0.05, ##p <0.01,
and ###p <0.001 compared to calcitriol, §p <0.05, §§p <0.01, and §§§p <0.001.
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around 40% (Figure 7B). Calcitriol also prevented TGF-
β1 and TGF-β2 mediated BEAS-2B cell migration as
noted in the scratch wound healing assay (Figure 8A).
Pretreatment with calcitriol significantly decreased the
effects of TGF-β1 and TGF-β2 by approximately 50%
(Figure 8B).
Discussion
In normal epithelium, injury to the epithelium leads to
the release of soluble factors including cytokines, chemo-
kines, prostaglandins, transforming growth factor (TGF),
epidermal growth factor (EGF), fibroblast growth factor
(FGF), matrix metalloproteinase (MMP), which can all
promote cell adhesion junction remodeling and migration
during wound repair [27]. Activation of fibroblasts and
myofibroblasts is important for wound closure and healing,
but may become aberrant in the presence of increased
inflammation. Myofibroblasts can originate from differ-
ent precursor cells including fibroblasts, mesenchymal
stem cells, bone marrow-derived mesenchymal stem
cells, smooth muscle cells, and epithelial cells which are
derived through induction of a process termed epithelial-
mesenchymal transition (EMT). Following injury to theepithelium, an epithelial cell will go through architectural
rearrangement to enable spreading, migration and secre-
tion of extracellular matrix (ECM) [27,28].
Chronic asthma is characterized by structural changes
in the lung termed airway remodeling resulting in a de-
cline in lung function regardless of anti-inflammatory
treatment [2]. The airway epithelial cells are at the front-
lines of protection in the airway. Following damage from
pollutants or allergens, the epithelium can repair itself
through initiation of the EMT process. In general, epi-
thelial stress will initiate the generation of mesenchymal
cells for tissue generation and tissue closure, with at-
tenuation of EMT following the completion of repair.
However, it is thought in the context of inflammation in
the asthmatic airway, the release of EMT signaling is
not discontinued, but amplified [29]. During the repair
process, cell-cell and cell-adhesion contacts are remodeled
with loss of the epithelial marker such as E-cadherin and
increased expression of mesenchymal markers of vimen-
tin, N-cadherin, and α-smooth muscle actin (α-SMA).
Additionally, epithelial cells will also secrete MMPs in
response TGF-β1, indicating a possible role in migration
of epithelial cells through the basement membrane [30].
These changes in the polarized epithelial cell result in
Figure 6 Calcitriol prevents TGF-β-mediated EMT: MMP2 and MMP9 mRNA and protein expression changes in BEAS-2B cells. BEAS-2B cells
were stimulated with the active form of Vitamin D, calcitriol (100 nM). After 24 hours, TGF-β1 (10 ng/ml) or TGF-β2 (10 ng/ml) was added to the cells
for an additional 48 hours. Total RNA was isolated and assessed for the expression of A: MMP2 (n =4) and B: MMP9 (n =4) by means of quantitative
real-time PCR. Expression levels were normalized to the housekeeping 18 s and calculated as mean level of induction in comparison to 0.1% vehicle
control cells. Data is presented as mean ± SEM *p <0.05, **p <0.01, and ***p <0.001 compared to control, #p <0.05, ##p <0.01, and ###p <0.001 compared
to calcitriol, §p <0.05, §§p <0.01, and §§§p <0.001 by one-way ANOVA. C: Conditioned supernatant of BEAS-2B cells stimulated with TGF-β1,
TGF-β2 and/or 100 nM calcitriol were subject to gelatin zymography. Results are representative of 3 separate experiments.
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motile and degrade the underlying ECM and move below
the epithelium. There is evidence to suggest that airway
remodeling and hyperresponsiveness in asthma may be
driven by repeated exposures to allergens or environmen-
tal toxins, leading to the inappropriate repair of airway
epithelial cells [31,32].
Eosinophils commonly secrete TGF-β. However other
cells including macrophages, lymphocytes, fibroblasts,
epithelial cells, and mast cells can also secrete TGF-β
[33]. The number of eosinophils found in the asthmatic
lung has been found to be increased in bronchial biop-
sies of asthmatic patients [34] and BAL fluid in mice
[35]. One of the major cytokines secreted by eosinophils
is that of TGF-β [36]. TGF-β has also been found to be
increased in the BAL fluid and tissue of asthmatic pa-
tients. However, which isoform is expressed and the tis-
sue location is still debatable. Overall, TGF-β1 [37] and
TGF-β2 [24] were found to be in higher amounts in the
BAL fluid of asthmatics compared to control patients.
Both TGF-β1 and TGF-β2 were found to be expressed
by eosinophils and contribute to increase number of eo-
sinophils in the airway [23,36,38]. The pathogenesis of
airway remodeling has been thought to be an activationof the epithelial-mesenchymal trophic unit in which in-
creased levels of TGF-β contribute to the activation of
epithelial cells to transform into myofibroblasts [39].
While TGF-β1 has been found to be involved in the
EMT process, it has not been established whether TGF-
β2 has the same effect. Our results here are consistent
with previous contributions in that we observe BEAS-2B
cells treated with TGF-β1 have increased markers of
EMT with a loss of E-cadherin. Conversely, TGF-β2
treatment of BEAS-2B cells presented an expression pat-
tern of EMT markers which was different from that in-
duced by TGF-β1.
Although the contribution of EMT in asthma is still
highly debated, there is evidence that epithelial cells con-
tribute to the pool of myofibroblasts [22]. This increase
in myofibroblasts may be a part of the airway remodeling
process as noted in chronic asthma. TGF-β1 has been
demonstrated to be responsible for differentiation into
myofibroblasts and this effect was found not be abrogated
by corticosteroid treatment [40,41]. Therefore, finding an
effective alternative therapy to anti-inflammatory drugs is
of great significance. Calcitriol was shown to prevent the
effects of EMT in rat lung and mouse lung fibroblasts
treated with TGF-β [42]. Anti-inflammatory effect of
Figure 7 Calcitriol inhibits TGF-β-induced invasiveness of BEAS-2B cells. BEAS-2B cells were stimulated with 100 nM calcitriol for 24 hours
followed by 48 hours of stimulation by 10 ng/ml of TGF-β1 or TGF-β2. BEAS-2B cells were isolated and reseeded onto 250 ug/ml of growth factor
reduced Matrigel™ coated transwell inserts at 1.5 × 105 cells/ml. Conditioned supernatant from these cells was used as the chemoattractant. After
48 hours, cells on the top of the inserts were removed and the remaining cells on the bottom were fixed and stained with the Diff-Quick stain
kit. A: Representative images of BEAS-2B cells which had migrated through the inserts in response to TGF-β treatment. B: Data represent an average of
cells counted in 5 random fields. Data is presented as mean ± SEM (n =4), **p <0.01 and ***p <0.001 compared to control, #p <0.05, p## <0.01, and
###p <0.001 compared to calcitriol treated cells, and §p <0.05 analyzed by one-way ANOVA.
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http://respiratory-research.com/content/15/1/146vitamin D on a steroid resistant gene was also observed in
airway smooth muscle cells treated with TNFα and IFNγ
[43]. We were, therefore, interested in observing the effects
of calcitriol on TGF-β treated BEAS-2B cells. Markers of
EMT, such as loss of E-cadherin, increased expression of
N-cadherin, and vimentin, were observed at the mRNA
and protein level following treatment with TGF-β1. This
increase in TGF-β was impeded by pre-stimulation with
calcitriol, as indicated by qPCR and Western blot. Our data
suggest that both TGF-β1 and TGF-β2 enhance BEAS-2B
cell invasion and MMP2 mRNA expression and that
this process is abrogated by calcitriol.
A recent study included adult asthma patients on the
inhaled ciclesonide and levalbuterol combined with an
initial dose of 100,000 IU of vitamin D3 followed by a
daily dose of 4,000 IU. In this study, there were no
differences in the indices of asthma control, asthma at-
tacks, or improved quality of life in adult asthmatics
compared to the placebo group. Sputum eosinophilia,
lung function, or airway hyperreactivity were also notimproved following treatment with Vitamin D3 [12].
However, in patients that had responded well to the vita-
min D3 treatment or had reached a 25-hydroxyvitmain
D level of 30 ng/ml or greater, these patients had a lower
rate of first exacerbation rates, and lower overall rates of
exacerbation and treatment failures [11]. Unfortunately,
the authors did not determine if vitamin D treatment modi-
fied sputum or blood inflammatory biomarkers. None-the-
less, these results support the therapeutic benefit of vitamin
D in allergic asthma, perhaps as an adjunct therapy. An-
other recent study investigated the role of vitamin D
supplementation in asthmatic children aged 6–18 years
with mild asthma and insufficient vitamin D levels. Fol-
lowing 6 weeks of 2,000 IU of vitamin D daily, there was
no difference in the effect of vitamin D compared to
placebo on methacholine challenge test, IgE levels, air-
way cytokines, and eosinophilia although there was a
significant increase in serum vitamin D levels. However,
the relatively small sample size of 36 patients of this
study prevents any discernable conclusions [13].
Figure 8 Calcitriol inhibits the migration of TGF-β stimulated BEAS-2B cells. BEAS-2B cells were stimulated with 100 nM calcitriol for 24 hours
followed by 48 hours of stimulation by 10 ng/ml of TGF-β1 or TGF-β2. A: Representative images of a wound healing scratch assay. Pictures of the
same area were taken at 0 and 48 hours at 20x magnification. The area of the wound was measured using the NIH ImageJ program. B: The % wound
closure was calculated and means of groups were compared by one-way ANOVA. Data is presented as mean ± SEM (n =4), *p <0.05 and **p <0.01
compared to control, ##p <0.01 compared to calcitriol treated cells, §p <0.05, §§p <0.01.
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http://respiratory-research.com/content/15/1/146The Institute of Medicine recommendations for ad-
equate vitamin D intake to maintain 25(OH)D3 serum
value at 20 ng/ml or 50 nM. However, many clinical la-
boratories continue to routinely report a value of 20 ng/ml
as inadequate and that value 21–29 ng/ml (52.5-72.5 nM)
are insufficient [44]. Vitamin D supplemented in the diet
of OVA-sensitized mice resulted in a decreased severity of
airway remodeling [45]. These mice, supplemented with
10,000 IU/kg or 2,000 IU/kg of vitamin D ended up with
serum 25(OH)D levels of 67.13 ng/ml and 31.00 ng/ml, re-
spectively [46]. Vitamin D supplementation reduced airway
hyperresponsiveness, airway remodeling, and BALF cyto-
kine levels [45]. However, vitamin D supplementation did
not fully reverse the effects of allergic airway inflammation.The physiological range of calcitriol has been observed to
be around 0.05 to 0.16 nmol/L. The ability of bronchial
epithelial cells to convert inactive vitamin D to its active
form has recently been demonstrated, indicating that the
local concentration of calcitriol is much higher at the local
cellular level [47]. Therefore, to address the difference be-
tween sufficient and supplementation values, higher calci-
triol levels of 100 nM were used in this study. While the
results of clinical trials utilizing vitamin D in asthma pa-
tients have inconsistent results, vitamin D supplementation
may still prove to be beneficial to those suffering with
asthma Additional careful and controlled studies are war-
ranted to address the controversy on the role of vitamin D
deficiency in the pathogenesis of asthma.
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http://respiratory-research.com/content/15/1/146The differences in mRNA and protein levels following
TGF-β1 or TGF-β2 stimulation suggest that the induction
of N-cadherin, snail, and vimentin may occur through dif-
ferent receptors. TGF-β binds to heterodimeric type I and
type II TGF-β receptors. There are seven type I receptors
and five type II receptors, of which the heterodimeric as-
sociation of these serine/threonine receptors determines
the specificity of the ligand signaling [48]. Co-receptors,
such as betaglycan, can also modulate TGF-β1 signaling
which is imperative for TGF-β2 signaling [45]. The mech-
anisms mediating EMT may be dependent on Smad when
stimulated with TGF-β1. This process may be increased in
the presence of cytokines, including TNF-α [30], IL-22
[49], IL-4 and IL-17 [50]. Johnson et al. [22] observed
increased expression and nuclear translocation of Snail,
a transcriptional repressor of E-cadherin and a potent
inducer of EMT, in the airway epithelial cells of HDM-
exposed mice and increased TGF-β upregulation follow-
ing allergen challenge. Furthermore, the authors also
found increased phosphorylated-Smad3 and Snail1 in
TGF-β/EGF-induced EMT [22]. Additionally, deficiency
in the PI3K inhibitor phosphatase and tensin homolog
(PTEN), has been associated with increased myofibroblast
differentiation [51]. Cytokines such as TNF-α could also
induce EMT through Snail stabilization and increased mi-
gration and invasion of tumor cells. The cytokine IL-6 was
recently shown to induce migration of bronchial epithelial
cells in PI3K/Akt/GSK-3β/β-catenin dependent manner
suggesting that this pathway may be contributing to the
mesenchymal population of cells often found in asthma
through induction of EMT signals [52,53]. TGF-β1 has
also been found to induce nuclear translocation of relA/
p65 of NF-κB, inducing NF-kB gene activity and down-
regulating PTEN promoter activity and protein expression
via NF-kB [54].
The findings in this study suggest that calcitriol pre-
vents the migration and invasion of TGF-β-treated
bronchial epithelial cells. The differences in mRNA
and protein data (Figure 5) indicate that calcitriol me-
diates this process through different mechanisms. Cal-
citriol has been shown to inhibit NF-κB nuclear
translocation into human bronchial smooth muscle
cells by decreasing importin α3 expression via VDR
[15]. VDR expression was found to be decreased in OVA-
sensitized and challenged mice fed with a vitamin D defi-
cient diet [55]. Therefore, importins represent a potential
target for vitamin D in alleviating allergic immune re-
sponses [56]. Also, deletion of VDR in mouse embryonic fi-
broblasts reduced the levels of NF-κB p65 protein and the
activity of translation regulators eIF2α and protein kinase R
[57]. Therefore, the underlying mechanisms of vitamin D
regulation and EMT and its involvement in airway remod-
eling in the airway need further elucidation and may be a
point of therapeutic interest.Conclusions
This data suggests that calcitriol regulates TGF-β1- and
TGF-β2-mediated EMT in bronchial epithelial cells. Given
the difference in EMT marker expression for TGF-β1 and
TGF-β2 treatment, calcitriol may be inhibiting TGF-β1/
β2-mediated-migration and invasion by different and yet
undefined cellular processes. Calcitriol may also be initiat-
ing its effects both at the mRNA transcript and protein
levels. Our results indicate a role for bronchial epithelial
cells in myofibroblast formation and thereby airway re-
modeling which may be inhibited by calcitriol.
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